slides · global inventory
Frame Problem
Slide function collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 5,849
Current window 4,291-4,320
Pages 195
Rows per page 30
Slide function
4,291-4,320 of 5,849
03
Uses a combination of pie charts for global stats and a process diagram for supply chain loss.AgroFresh | Investor Presentation Deck | 20 slides · AgroFresh
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
11
The slide uses a split-layout: left side defines the condition and market size, right side details the clinical and regulatory pain points.ATAI | Investor Presentation Deck | 36 slides · atai Life Sciences
Pitch deck Investor relations 1 hit
20
The slide uses a split-layout: left side defines the condition and global burden, right side details the 'huge need for development' using a vertical timeline-like list.ATAI | Investor Presentation Deck | 36 slides · atai Life Sciences
Pitch deck Investor relations 1 hit
17
The slide illustrates the 'Approach' side of the conflict; the 'Avoidance' side is implied by the context of SAD.Bionomics | Investor Presentation Deck | 59 slides · Bionomics
Pitch deck Investor relations 1 hit
23
Bionomics | Investor Presentation Deck | 59 slidesBionomics | Investor Presentation Deck | 59 slides · Bionomics
Pitch deck Investor relations Beat · Solution1 hit
03
Uses a before-after-bridge style structure to contrast vaccine efficacy with remaining clinical challenges.Blue Water Vaccines | Results Presentation Deck | 15 slides · Blue Water Vaccines
Conference presentation Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
12
The diagram uses question marks to represent the unknown or challenging nature of integrating different protein types into the central platform.Blue Water Vaccines | Results Presentation Deck | 15 slides · Blue Water Vaccines
Conference presentation Investor relations Beat · SolutionLoop · Jobs To Be Done1 hit
14
The slide uses a comparison table structure to differentiate between Mucosal PV and Mucocutaneous PV, followed by a list of clinical limitations of current standard-of-care treatments.Cabaletta Bio | Investor Presentation Deck | 23 slides · Cabaletta Bio
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
17
Includes a molecular structure diagram of MuSK and a pie chart of MG patient segments.Cabaletta Bio | Investor Presentation Deck | 23 slides · Cabaletta Bio
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
17
The slide uses a three-row layout to contrast the problem, current limitations, and the proposed solution.Dare Bioscience | Investor Presentation Deck | 50 slides · Daré Bioscience
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
25
The slide uses a vertical effectiveness scale to position existing methods and highlight the 'missing' product category.Dare Bioscience | Investor Presentation Deck | 50 slides · Daré Bioscience
Pitch deck Investor relations 1 hit
31
Uses a visual inequality symbol to emphasize the distinction between FSAD and HSDD.Dare Bioscience | Investor Presentation Deck | 50 slides · Daré Bioscience
Pitch deck Investor relations 1 hit
47
The slide uses a comparative structure to frame the problem (limitations of current standard) and the solution (target product profile).Dare Bioscience | Investor Presentation Deck | 50 slides · Daré Bioscience
Pitch deck Investor relations 1 hit
13
The slide uses a biological process diagram to illustrate the mechanism of immune cell activation.Enochian Biosciences | Investor Presentation Deck | 39 slides · Enochian BioSciences
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
14
The slide uses a visual metaphor to explain immune evasion.Enochian Biosciences | Investor Presentation Deck | 39 slides · Enochian BioSciences
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
08
Uses a biological analogy (brake pedal) to explain gene function.Genprex | Investor Presentation Deck | 39 slides · Genprex
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
26
The slide uses a pie chart to illustrate the market split between Type 1 and Type 2 diabetes.Genprex | Investor Presentation Deck | 39 slides · Genprex
Pitch deck Investor relations 1 hit
28
The slide uses a two-column layout to present various medical conditions caused by diabetes, supported by statistical data points.Genprex | Investor Presentation Deck | 39 slides · Genprex
Pitch deck Investor relations 1 hit
08
Uses a biological analogy (brake pedal) to explain gene function.Genprex | Investor Presentation Deck | 44 slides · Genprex
Pitch deck Investor relations Beat · Need1 hit
26
Genprex | Investor Presentation Deck | 44 slidesGenprex | Investor Presentation Deck | 44 slides · Genprex
Pitch deck Investor relations 1 hit
28
Genprex | Investor Presentation Deck | 44 slidesGenprex | Investor Presentation Deck | 44 slides · Genprex
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
29
The slide uses a timeline to establish the long-standing nature of the problem and positions the new therapy as a transformative solution.Genprex | Investor Presentation Deck | 44 slides · Genprex
Pitch deck Investor relations 1 hit
05
The diagram uses a bullseye/concentric circle framework to show the hierarchy from disease down to the molecular level.Hepion Pharmaceuticals | Results Presentation Deck | 34 slides · Hepion Pharmaceuticals
Pitch deck Investor relations 1 hit
11
The slide uses a process diagram to show disease progression and three columns to define the specific conditions.Hepion Pharmaceuticals | Results Presentation Deck | 34 slides · Hepion Pharmaceuticals
Pitch deck Investor relations 1 hit
12
Hepion Pharmaceuticals | Results Presentation Deck | 34 slidesHepion Pharmaceuticals | Results Presentation Deck | 34 slides · Hepion Pharmaceuticals
Pitch deck Investor relations 1 hit
05
The slide uses a medical context to establish the urgency and market need for a new therapy.Larimar Therapeutics | Investor Presentation Deck | 32 slides · Larimar Therapeutics
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
13
Includes medical imagery of fungal cells and brain infection.Matinas BioPharma | Investor Presentation Deck | 31 slides · Matinas BioPharma
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
04
The slide uses a central hub-and-spoke diagram to show the mast cell as the central point of failure/intervention.Third Harmonic Bio | Investor Presentation Deck | 20 slides · Third Harmonic Bio
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
05
Includes a patient quote and clinical imagery to emphasize the severity of the condition.Third Harmonic Bio | Investor Presentation Deck | 20 slides · Third Harmonic Bio
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
06
Third Harmonic Bio | Investor Presentation Deck | 20 slidesThird Harmonic Bio | Investor Presentation Deck | 20 slides · Third Harmonic Bio
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit